<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee18039cc63">
<name type="corporate">
 <namePart>United States Government Publishing Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
  <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
</role>
 <role>
  <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
  <roleTerm authority="marcrelator" type="code">dst</roleTerm>
</role>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Government Accountability Office</namePart>
 <namePart>National Security and International Affairs Division</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">author</roleTerm>
  <roleTerm authority="marcrelator" type="code">aut</roleTerm>
</role>
 <description>Government Organization</description>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="marcgt">government publication</genre>
<language>
 <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<extension>
 <collectionCode>GAOREPORTS</collectionCode>
 <category>Legislative Agency Publications</category>
 <waisDatabaseName>gao</waisDatabaseName>
 <branch>legislative</branch>
 <dateIngested>2010-08-12</dateIngested>
</extension>
<originInfo>
 <publisher>U.S. Government Printing Office</publisher>
 <dateIssued encoding="w3cdtf">1998-03-12</dateIssued>
 <issuance>monographic</issuance>
</originInfo>
<physicalDescription>
 <note type="source content type">deposited</note>
 <digitalOrigin>born digital</digitalOrigin>
 <extent>22 p.</extent>
</physicalDescription>
<classification authority="sudocs">GA 1.13:T-NSIAD-98-116</classification>
<identifier type="uri">https://www.govinfo.gov/app/details/GAOREPORTS-T-NSIAD-98-116</identifier>
<identifier type="local">P0b002ee18039cc63</identifier>
<identifier type="former package identifier">f:ns98116t</identifier>
<recordInfo>
 <recordContentSource authority="marcorg">DGPO</recordContentSource>
 <recordCreationDate encoding="w3cdtf">2010-08-12</recordCreationDate>
 <recordChangeDate encoding="w3cdtf">2011-03-23</recordChangeDate>
 <recordIdentifier source="DGPO">GAOREPORTS-T-NSIAD-98-116</recordIdentifier>
 <recordOrigin>machine generated</recordOrigin>
 <languageOfCataloging>
  <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</languageOfCataloging>
</recordInfo>
<accessCondition type="GPO scope determination">fdlp</accessCondition>
<extension>
 <docClass>REPORT</docClass>
 <accessId>GAOREPORTS-T-NSIAD-98-116</accessId>
 <reportNumber>T-NSIAD-98-116</reportNumber>
 <subject>Narcotics</subject>
 <subject>Drug trafficking</subject>
 <subject>Political corruption</subject>
 <subject>Law enforcement</subject>
 <subject>International relations</subject>
 <subject>Foreign policies</subject>
 <subject>Strategic planning</subject>
 <subject>Budget cuts</subject>
 <subject>Foreign governments</subject>
 <subject>International cooperation</subject>
 <identifier>National Drug Control Strategy</identifier>
 <identifier>Caribbean</identifier>
 <identifier>Mexico</identifier>
 <identifier>Colombia</identifier>
 <identifier>Peru</identifier>
 <type>Testimony</type>
 <seriesAbbrev>NSIAD</seriesAbbrev>
 <law congress="103" isPrivate="false" number="62"></law>
 <USCode title="22">
                      <section number="2291j"></section>
                </USCode>
</extension>
<titleInfo>
 <title>Drug Control: Status of U.S. International Counternarcotics Activities</title>
</titleInfo>
<abstract>GAO discussed its observations on the effectiveness of U.S. efforts to
combat drug production and the movement of drugs into the United States,
focusing on: (1) the challenges of addressing international
counternarcotics issues; (2) obstacles to implementation of U.S. drug
control efforts; and (3) areas requiring attention to improve the
operational effectiveness of U.S. drug control efforts.&lt;p/&gt;GAO noted that: (1) despite long-standing efforts and expenditures of
billions of dollars, illegal drugs still flood the United States; (2)
although U.S. counternarcotics efforts have resulted in the arrest of
major drug traffickers, the seizure of large amounts of drugs, and the
eradication of illicit drug crops, they have not materially reduced the
availability of drugs in the United States; (3) the United States and
drug-producing and -transiting nations face a number of obstacles in
attempting to reduce the production of and trafficking in illegal drugs;
(4) international drug-trafficking organizations are sophisticated,
multibillion-dollar industries that quickly adapt to new U.S. drug
control efforts; (5) as success is achieved in one area, the
drug-trafficking organizations change tactics, thwarting U.S. efforts;
(6) there are also other obstacles that impede U.S. and drug producing
and -transiting countries&apos; drug control efforts; (7) in the
drug-producing and -transiting countries, counternarcotics efforts are
constrained by corruption, competing economic and political policies,
inadequate laws, limited resources and institutional capabilities, and
internal problems such as terrorism and civil unrest; (8) morever, drug
traffickers are increasingly resourceful in corrupting the countries&apos;
institutions; (9) for its part, the United States has not been able to
maintain a well-organized and consistently funded international
counternarcotics program; (10) U.S. efforts have also been hampered by
competing U.S. foreign policy objectives, organizational and operational
limitations, and the lack of clear goals and objectives; (11) since
GAO&apos;s February 1997 report, some countries, with U.S. assistance, have
taken steps to improve their capacity to reduce the flow of illegal
drugs into the United States; (12) these countries have taken action to
extradite drug criminals; enacted legislation to control organized
crime, money laundering, and chemicals used in the production of illicit
drugs; and instituted reforms to reduce corruption; and (13) while these
actions represent positive steps, it is too early to determine their
impact, and challenges remain.</abstract>
<location>
 <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-T-NSIAD-98-116/html/GAOREPORTS-T-NSIAD-98-116.htm</url>
 <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-T-NSIAD-98-116/pdf/GAOREPORTS-T-NSIAD-98-116.pdf</url>
</location>
<identifier type="preferred citation">GAO/T-NSIAD-98-116</identifier>
<location>
 <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/GAOREPORTS-T-NSIAD-98-116</url>
</location>
<note>Testimony</note>
<extension>
 <searchTitle>GAO/T-NSIAD-98-116; Drug Control: Status of U.S. International Counternarcotics Activities;
            </searchTitle>
</extension>
<subject>
 <topic>Narcotics</topic>
 <topic>Drug trafficking</topic>
 <topic>Political corruption</topic>
 <topic>Law enforcement</topic>
 <topic>International relations</topic>
 <topic>Foreign policies</topic>
 <topic>Strategic planning</topic>
 <topic>Budget cuts</topic>
 <topic>Foreign governments</topic>
 <topic>International cooperation</topic>
 <topic>National Drug Control Strategy</topic>
 <topic>Caribbean</topic>
 <topic>Mexico</topic>
 <topic>Colombia</topic>
 <topic>Peru</topic>
</subject>
<relatedItem type="isReferencedBy">
 <titleInfo>
  <title>United States Code</title>
  <partNumber>Title 22 Section 2291j</partNumber>
</titleInfo>
 <identifier type="USC citation">22 U.S.C. 2291j</identifier>
</relatedItem>
<relatedItem type="isReferencedBy">
 <titleInfo>
  <title>United States Public Law 62 (103rd Congress)</title>
</titleInfo>
 <identifier type="public law citation">Public Law 103-62</identifier>
</relatedItem>
</mods>